Ixabepilone Products | Cleanchem - Ivosidenib is a targeted cancer therapy used to treat acute myeloid leukemia (AML) with an IDH1 mutation. It works by inhibiting the mutant IDH1 enzyme, which helps reduce the proliferation of leukemia cells and improve patient outcomes.

Cat. No: CL-IZMB-01

CAS No: 219989-84-1

Mol. F: C27H42N2O5S

Mol. Wt: 506.7

Inv. Status: Custom Synthesis

Cat. No: CL-IZMB-02

CAS No: 1220999-09-6

Mol. F: C27H44N2O6S

Mol. Wt: 524.7

Inv. Status: Custom Synthesis

Cat. No: CL-IZMB-03

CAS No: 219989-85-2

Mol. F: C26H40N2O5S

Mol. Wt: 492.7

Inv. Status: Custom Synthesis

Cat. No: CL-IZMB-04

CAS No: 444197-71-1

Mol. F: C27H42N2O5S

Mol. Wt: 506.7

Inv. Status: Custom Synthesis

Cat. No: CL-IZMB-05

CAS No: 1220999-07-4

Mol. F: C27H42N2O5S

Mol. Wt: 506.7

Inv. Status: Custom Synthesis